Acupuncture improves the emotion domain and lipid profiles in women with polycystic ovarian syndrome: a secondary analysis of a randomized clinical trial
Frontiers in Endocrinology · 2023
DOI: 10.3389/fendo.2023.1237260 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Frontiers in Endocrinology, 2023. Verfasst von Hui Chang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Heilongjiang University of Chinese Medicine, Harbin, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Acupuncture Therapy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aims to evaluate the effect of acupuncture on the emotion domain and metabolic parameters of Chinese women with polycystic ovarian syndrome (PCOS) by secondary analysis of a randomized clinical trial, conducted from 6 July 2012 to 7 October 2015.
Method
In this study, we investigated the effects of acupuncture (458 patients) and sham acupuncture (468 patients) on metabolic parameters, serum ions, and all quality-of-life scale scores related to PCOS. The quality of life of patients was evaluated using five relevant scales, operated by the research assistant, namely, PCOSQ, SF-36, and ChiQOL, as well as Zung-SAS and Zung-SDS. Metabolic parameters and serum ions were measured.
Results
A reduction in acne score, AN, Hcy, and LDL-C, and an increase in the level of lipoprotein α, Apo A1, and Apo A1/Apo B were observed in the acupuncture group after 4 months’ intervention after adjusting clomiphene and reproductive outcome ( p < 0.05). An increase in SF-36 total scores, RP and RE scores, ChiQOL total scores, and emotion domain scores was observed in the acupuncture group after 4 months’ intervention, while PF and HT scores were decreased (adjusted p < 0.05). Those same changes were observed in sham acupuncture. Meanwhile, the serum levels of Ca, K, and Cl were elevated in the acupuncture group after the interventions (adjusted p < 0.005). There were no significant differences in HOMA-IR, MetS, FPG, FINS, HDL-C, TG, Apo B, and level of serum P, Mg, and Na. Also, no changes in BP, GH, VT, SF, physical form domain, and spirit domain were observed after treatment.
Conclusion
Acupuncture can improve not only the emotional changes in SF-36 scores and ChiQOL scores, but also lipid metabolism, implying that it may have a correlation between emotional change and lipid metabolism. Furthermore, acupuncture can also regulate the changes of serum Ca, K, and Cl. Clinical trial registration ClinicalTrials.gov , identifier NCT01573858.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heilongjiang University of Chinese Medicine, Harbin, China.
- First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
- Affiliated Hospital of Jiangsu University, Zhenjiang, China.
- Nanjing Universityg, Nanjin, China.
- The Chinese University of Hong Kong, Hong Kong, Hong Kong, SAR, China.
- Heilongjiang Provincial Hospital, Harbin, China.
Zitieren
APA
Chang, H., Shi, B., Ge, H., Liu, C., Wang, L., Ma, C., Liu, L., Zhang, W., Zhang, D., Wang, Y., Wang, C. C., & Wu, X. (2023). Acupuncture improves the emotion domain and lipid profiles in women with polycystic ovarian syndrome: a secondary analysis of a randomized clinical trial. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2023.1237260
Vancouver
Chang H, Shi B, Ge H, Liu C, Wang L, Ma C, et al. Acupuncture improves the emotion domain and lipid profiles in women with polycystic ovarian syndrome: a secondary analysis of a randomized clinical trial. Frontiers in Endocrinology. 2023. doi:10.3389/fendo.2023.1237260
BibTeX
@article{Chang2023,
author = {Chang, Hui and Shi, Baichao and Ge, Hang and Liu, Chengdong and Wang, Lirong and Ma, Chengcheng and Liu, Lifeng and Zhang, Wanyu and Zhang, Duojia and Wang, Yong and Wang, Chi Chiu and Wu, Xiaoke},
title = {Acupuncture improves the emotion domain and lipid profiles in women with polycystic ovarian syndrome: a secondary analysis of a randomized clinical trial},
journal = {Frontiers in Endocrinology},
year = {2023},
doi = {10.3389/fendo.2023.1237260}
}
EUVIMED